Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression
- PMID: 28452036
- DOI: 10.1007/s12032-017-0965-7
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression
Abstract
In an era of personalized treatment, there is a great interest in identifying factors which might predict patient response to radiotherapy (RT). The role of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinoma (HNSCC) remains still controversial. We performed a retrospective analysis on the prognostic value of EGFR in HNSCC patients treated with surgery and postoperative RT through a semiquantitative immunohistochemical analysis of EGFR membrane expression. We retrospectively analyzed 65 HNSCC patients treated in our Institute from 1997 to 2003 who underwent adjuvant RT after surgery. Median follow-up was 43.5 months (range 0.2-173 months). None of these patients were treated with postoperative concomitant chemotherapy. Tumor samples were obtained from surgical specimens. Membrane features (intensity, extension) of EGFR expression were evaluated, and a statistical analysis (univariate and multivariate) was conducted to correlate these parameters with overall survival (OS) and disease-free survival (DFS). Patients with an intense and complete labeling of EGFR presented worse OS and DFS compared with groups obtained by all other possible combination, and the difference was borderline statistically significant (P = 0.08 for OS and P = 0.006 for DFS). Moreover, a stratification of patients was performed considering EGFR expression on the tumor tissue and classifying its distribution as "homogeneous" or "heterogeneous." We found that patients showing an "heterogeneous" EGFR expression distribution had worse OS and DFS compared to the "homogeneous" group of patients. Based on our results, EGFR expression, especially referring to membrane features (semiquantitative analysis), might have a prognostic value for OS and DFS in locally advanced HNSCC treated with surgery and adjuvant RT. Prospective trials could be useful to confirm the prognostic role of EGFR expression and also to assess a predictive role to select that might benefit from more aggressive treatments.
Keywords: Biomarkers; EGFR expression; Head and neck cancers; Radiotherapy.
Similar articles
-
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma.Oncotarget. 2016 Nov 8;7(45):74362-74379. doi: 10.18632/oncotarget.11413. Oncotarget. 2016. PMID: 27556186 Free PMC article. Review.
-
Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.J BUON. 2015 Jul-Aug;20(4):943-53. J BUON. 2015. PMID: 26416042 Review.
-
c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):701-7. doi: 10.1016/j.ijrobp.2013.11.013. Int J Radiat Oncol Biol Phys. 2014. PMID: 24521684
-
Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.Tumour Biol. 2014 Mar;35(3):2285-95. doi: 10.1007/s13277-013-1303-0. Tumour Biol. 2014. PMID: 24234257
-
Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer.Clin Transl Oncol. 2014 Apr;16(4):418-24. doi: 10.1007/s12094-013-1099-9. Epub 2013 Nov 6. Clin Transl Oncol. 2014. PMID: 24193865
Cited by
-
Influence of EGF and pro-NGF on EGFR/SORTILIN interaction and clinical impact in head and neck squamous cell carcinoma.Front Oncol. 2023 Jul 27;13:661775. doi: 10.3389/fonc.2023.661775. eCollection 2023. Front Oncol. 2023. PMID: 37576898 Free PMC article.
-
DNA damage response and potential biomarkers of radiosensitivity in head and neck cancers: clinical implications.Rom J Morphol Embryol. 2023 Jan-Mar;64(1):5-13. doi: 10.47162/RJME.64.1.01. Rom J Morphol Embryol. 2023. PMID: 37128786 Free PMC article. Review.
-
Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma.Front Med (Lausanne). 2023 Feb 2;10:1066021. doi: 10.3389/fmed.2023.1066021. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36817764 Free PMC article. Review.
-
Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.Front Oncol. 2022 Jul 25;12:885236. doi: 10.3389/fonc.2022.885236. eCollection 2022. Front Oncol. 2022. PMID: 35957892 Free PMC article.
-
EGFR Mutations in Head and Neck Squamous Cell Carcinoma.Int J Mol Sci. 2022 Mar 30;23(7):3818. doi: 10.3390/ijms23073818. Int J Mol Sci. 2022. PMID: 35409179 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous